- Home
- DTI vs CRBP Comparison
DTI vs CRBP Comparison
Compare DTI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- CRBP
- Stock Information
- Founded
- DTI 1984
- CRBP 2009
- Country
- DTI United States
- CRBP United States
- Employees
- DTI N/A
- CRBP N/A
- Industry
- DTI Metal Fabrications
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- CRBP Health Care
- Exchange
- DTI Nasdaq
- CRBP Nasdaq
- Market Cap
- DTI 68.0M
- CRBP 73.4M
- IPO Year
- DTI N/A
- CRBP N/A
- Fundamental
- Price
- DTI $2.62
- CRBP $7.42
- Analyst Decision
- DTI Strong Buy
- CRBP Strong Buy
- Analyst Count
- DTI 1
- CRBP 10
- Target Price
- DTI $5.50
- CRBP $53.56
- AVG Volume (30 Days)
- DTI 56.0K
- CRBP 114.7K
- Earning Date
- DTI 05-13-2025
- CRBP 05-06-2025
- Dividend Yield
- DTI N/A
- CRBP N/A
- EPS Growth
- DTI N/A
- CRBP N/A
- EPS
- DTI N/A
- CRBP N/A
- Revenue
- DTI $160,352,000.00
- CRBP N/A
- Revenue This Year
- DTI $4.26
- CRBP N/A
- Revenue Next Year
- DTI $6.26
- CRBP $150.00
- P/E Ratio
- DTI N/A
- CRBP N/A
- Revenue Growth
- DTI 8.19
- CRBP N/A
- 52 Week Low
- DTI $1.43
- CRBP $4.64
- 52 Week High
- DTI $6.36
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- DTI 57.72
- CRBP 53.76
- Support Level
- DTI $2.34
- CRBP $7.05
- Resistance Level
- DTI $2.79
- CRBP $7.62
- Average True Range (ATR)
- DTI 0.23
- CRBP 0.50
- MACD
- DTI 0.02
- CRBP -0.01
- Stochastic Oscillator
- DTI 70.69
- CRBP 55.97
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.